Clinical Trial Update: A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis

View source ↗

Summary

A completed retrospective Swedish cohort study examining health outcomes, life expectancy, resource use and costs in patients with a history of myocardial infar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Not disclosed

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Status: COMPLETED